Importer of Controlled Substances Application: Southern Ohio Correctional Facility, 36947-36948 [2019-16165]
Download as PDF
<![CDATA[
36947
Federal Register / Vol. 84, No. 146 / Tuesday, July 30, 2019 / Notices
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before September 30, 2019.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
DATES:
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: Research
Triangle Institute
ACTION:
Notice of application.
SUPPLEMENTARY INFORMATION:
In accordance with 21 CFR
1301.33(a), this is notice that on May 23,
2019, Research Triangle Institute, 3040
East Cornwallis Road, Hermann
Building, Room 106, Research Triangle
Park, North Carolina 27709, applied to
be registered as a bulk manufacturer of
the following basic class of controlled
substance:
Controlled substance
Drug code
Tetrahydrocannabinols ..........................................................................................................................................
The company will manufacture via
synthesis, Tetrahydrocannabinols (7370)
for use by customers as analytical
reference standards.
Dated: July 16, 2019.
John J. Martin,
Assistant Administrator.
Drug Enforcement Administration
[Docket No. DEA–392]
[FR Doc. 2019–16175 Filed 7–29–19; 8:45 am]
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before September 30, 2019.
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
SUPPLEMENTARY INFORMATION:
In accordance with 21 CFR
1301.33(a), this is notice that on March
18, 2019, AMPAC Fine Chemicals LLC,
Highway 50 and Hazel Avenue,
Building 05001, Rancho Cordova,
California 95670 applied to be registered
as bulk manufacturer of the following
basic classes of controlled substances:
Controlled substance
Drug code
Methylphenidate .....................................................................................................................................................
Levomethorphan ....................................................................................................................................................
Levorphanol ...........................................................................................................................................................
Thebaine ................................................................................................................................................................
Tapentadol .............................................................................................................................................................
Remifentanil ...........................................................................................................................................................
The company plans to manufacture
the listed controlled substances for
distribution to its customers.
Dated: July 16, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019–16177 Filed 7–29–19; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
jspears on DSK3GMQ082PROD with NOTICES
[Docket No. DEA–392]
Importer of Controlled Substances
Application: Southern Ohio
Correctional Facility
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic class, and applicants
DATES:
VerDate Sep<11>2014
16:42 Jul 29, 2019
Jkt 247001
therefore, may file written comments on
or objections to the issuance of the
proposed registration or the proposed
authorization to import on or before
August 29, 2019. Such persons may also
file a written request for a hearing on
the application for registration and for
authorization to import on or before
August 29, 2019.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for hearing
a should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
I
ADDRESSES:
DEPARTMENT OF JUSTICE
Bulk Manufacturer of Controlled
Substances Application: AMPAC Fine
Chemicals LLC
BILLING CODE 4410–09–P
7370
Schedule
1724
9210
9220
9333
9780
9739
Schedule
II
II
II
II
II
II
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION:
Pursuant to 21 U.S.C. 958(i), prior to
issuing a regulation under 21 U.S.C.
952(a)(2)(B) authorizing the importation
of a controlled substance in schedule I
or II, DEA is required to provide
manufacturers holding registrations for
the bulk manufacture of the substance
an opportunity for a hearing.
Additionally, pursuant to 21 CFR
1301.34(a), DEA shall, upon the filing of
an application for registration to import
a controlled substance in schedule I or
II under 21 U.S.C. 952(a)(2)(B), provide
notice and the opportunity to request a
hearing to manufacturers holding
registrations for the bulk manufacture of
the substance and to applicants for such
registrations.
E:\FR\FM\30JYN1.SGM
30JYN1
36948
Federal Register / Vol. 84, No. 146 / Tuesday, July 30, 2019 / Notices
requests should be addressed as
described above.
Therefore, in accordance with 21
U.S.C. 958(i) and 21 CFR 1301.34(a),
this is notice that on January 31, 2017,
Southern Ohio Correctional Facility,
1724 State Route 728, Lucasville, Ohio
45699, applied to be registered as an
importer of Pentobarbital (2270), a basic
class of controlled substance listed in
schedule II.
The facility intends to import the
above-listed controlled substance for
legitimate use. This particular
controlled substance is not available for
the intended legitimate use within the
current domestic supply of the United
States.
Any bulk manufacturer who is
presently, or is applying to be,
registered with DEA to manufacture this
basic class of controlled substance may
file comments or objections to the
issuance of the proposed registration or
to the authorization of this importation,
and may, at the same time, file a written
request for a hearing. Any such
comments, objections, or hearing
Dated: July 16, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019–16165 Filed 7–29–19; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Application: Chattem Chemicals
ACTION:
Notice of application.
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for a
hearing should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION:
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before August 29, 2019.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
DATES:
In accordance with 21 CFR
1301.34(a), this is notice that on May 17,
2019, Chattem Chemicals Inc., 3801
Saint Elmo Avenue, Chattanooga,
Tennessee 37409–1237 applied to be
registered as an importer of the
following basic classes of controlled
substances:
Controlled substance
Drug code
Methamphetamine .........................................................................................................................................................
4-Anilino-N-phenethyl-4-piperidine (ANPP) ...................................................................................................................
Phenylacetone ...............................................................................................................................................................
Opium, raw ....................................................................................................................................................................
Poppy Straw Concentrate ..............................................................................................................................................
Tapentadol .....................................................................................................................................................................
The company plans to import the
listed controlled substances to
manufacture bulk controlled substances
for sale to its customers. The company
plans to import an intermediate of
Tapentadol (9780), to bulk manufacture
Tapentadol for distribution to its
customers.
SUMMARY:
Dated: July 16, 2019.
John J. Martin,
Assistant Administrator.
DATES:
Comments are encouraged and
will be accepted for 30 days until
August 29, 2019.
[FR Doc. 2019–16172 Filed 7–29–19; 8:45 am]
DEPARTMENT OF JUSTICE
jspears on DSK3GMQ082PROD with NOTICES
[OMB Number 1121–NEW]
Agency Information Collection
Activities; Proposed eCollection
eComments Requested; New
Collection: Methodological Research
To Support the National Crime
Victimization Survey Redesign
Program: National Survey of Crime and
Safety—Field Test
Bureau of Justice Statistics,
Department of Justice.
ACTION: 30-Day notice.
AGENCY:
16:42 Jul 29, 2019
Jkt 247001
If
you have additional comments
especially on the estimated public
burden or associated response time,
suggestions, or need a copy of the
proposed information collection
instrument with instructions or
additional information, please contact
Jennifer Truman, Statistician, Bureau of
Justice Statistics, 810 Seventh Street
NW, Washington, DC 20531 (email:
jennifer.truman@usdoj.gov; telephone:
202–514–5083).
FOR FURTHER INFORMATION CONTACT:
BILLING CODE 4410–09–P
VerDate Sep<11>2014
The Department of Justice
(DOJ), Office of Justice Programs,
Bureau of Justice Statistics, will be
submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00065
Fmt 4703
Sfmt 4703
1105
8333
8501
9600
9670
9780
Schedule
II
II
II
II
II
II
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the Bureau of Justice
Statistics, including whether the
information will have practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Evaluate whether and if so how the
quality, utility, and clarity of the
information to be collected can be
enhanced; and
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms
of information technology, e.g.,
permitting electronic submission of
responses.
Overview of This Information
Collection
(1) Type of Information Collection:
New collection under activities related
E:\FR\FM\30JYN1.SGM
30JYN1
]]>Agencies
[Federal Register Volume 84, Number 146 (Tuesday, July 30, 2019)]
[Notices]
[Pages 36947-36948]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-16165]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Application: Southern Ohio
Correctional Facility
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic class, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration or the proposed authorization to
import on or before August 29, 2019. Such persons may also file a
written request for a hearing on the application for registration and
for authorization to import on or before August 29, 2019.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
requests for hearing a should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION:
Pursuant to 21 U.S.C. 958(i), prior to issuing a regulation under
21 U.S.C. 952(a)(2)(B) authorizing the importation of a controlled
substance in schedule I or II, DEA is required to provide manufacturers
holding registrations for the bulk manufacture of the substance an
opportunity for a hearing. Additionally, pursuant to 21 CFR 1301.34(a),
DEA shall, upon the filing of an application for registration to import
a controlled substance in schedule I or II under 21 U.S.C.
952(a)(2)(B), provide notice and the opportunity to request a hearing
to manufacturers holding registrations for the bulk manufacture of the
substance and to applicants for such registrations.
[[Page 36948]]
Therefore, in accordance with 21 U.S.C. 958(i) and 21 CFR
1301.34(a), this is notice that on January 31, 2017, Southern Ohio
Correctional Facility, 1724 State Route 728, Lucasville, Ohio 45699,
applied to be registered as an importer of Pentobarbital (2270), a
basic class of controlled substance listed in schedule II.
The facility intends to import the above-listed controlled
substance for legitimate use. This particular controlled substance is
not available for the intended legitimate use within the current
domestic supply of the United States.
Any bulk manufacturer who is presently, or is applying to be,
registered with DEA to manufacture this basic class of controlled
substance may file comments or objections to the issuance of the
proposed registration or to the authorization of this importation, and
may, at the same time, file a written request for a hearing. Any such
comments, objections, or hearing requests should be addressed as
described above.
Dated: July 16, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019-16165 Filed 7-29-19; 8:45 am]
BILLING CODE 4410-09-P
